Analysis AtriCure Inc (ATRC)
5/31/2024
Analysis of AtriCure Inc (ATRC)
AtriCure Inc (ATRC) is showing some interesting trends based on the provided data:1. Price Movement: The stock price has been fluctuating over the past few days, with the price closing at $34.48, opening at $35.87, and reaching a high of $36.28 and a low of $34.42. This indicates some volatility in the stock.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) is currently at 77.91, which is considered overbought. This may suggest a potential reversal or correction in the stock price.
- MACD Indicator: The MACD line is at 0.44, above the signal line of -0.51, with a positive MACD histogram of 0.95. This indicates a bullish signal for the stock.
3. Moving Averages:
- The Simple Moving Average (SMA) is at 22.96, the Exponential Moving Average (EMA) is at 23.98, and the Weighted Moving Average (WMA) is at 23.20. These moving averages can be used to identify trends in the stock price.
Overall, AtriCure Inc is currently in an interesting position with some conflicting signals. Traders and investors may want to closely monitor the stock for potential trading opportunities based on these indicators.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This suggests an increase from the EPS of $6.59 reported for the current fiscal year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing growth in both the quarterly and annual periods.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, the following conclusions can be drawn:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates indicate a generally positive outlook for the company, with expected growth in both quarterly and annual sales over the coming years.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions about the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still projected to be positive.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $200. However, there is a wide range of estimates, from a low of $164 to a high of $250. The current price of the security is below both the median and average forecast, suggesting that there may be potential for growth according to analysts.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a fiscal year ending on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 15.31 billion float shares and 99.29 million shares shorted. The stock outstanding is 15.33 billion, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65.
The stock price summary includes a beta of 1.264, 50-day moving average of $176.26, and 200-day moving average of $181.04. The 52-week range is between $164.08 and $199.62, with a 52-week change of 6.85%.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date on May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a trailing annual dividend yield of 0.51%.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the past four fiscal years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the net income has also shown a positive trend, rising from $57.4 billion in 2020 to $97 billion in 2023.
3. The company's EBITDA has also been increasing over the years, indicating improved operational efficiency and profitability.
4. The basic and diluted earnings per share (EPS) have remained relatively stable over the years, with slight fluctuations.
5. The company has been able to maintain a healthy gross profit margin, although the cost of goods sold has also increased with the rise in sales.
6. Operating income and EBIT have shown an upward trend, reflecting the company's ability to effectively manage its operating expenses.
7. The company has been able to generate consistent income from its core operations, as seen in the net income from continuous operations.
8. Overall, the financial performance of the company seems to be on a positive trajectory, with increasing revenues and profitability over the years.
Balance Sheet
These are balance sheets. Here are the conclusions based on the provided data:1. The total assets have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. Current assets fluctuate from year to year, with the highest value of $162,819,000,000 in 2019.
3. Non-current assets have been increasing steadily, with the highest value of $234,386,000,000 in 2018.
4. Total liabilities have also been increasing, reaching the highest value of $302,083,000,000 in 2022.
5. Shareholders' equity has been fluctuating, with the highest value of $90,488,000,000 in 2019.
6. The company has been relying more on non-current assets to finance its operations, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been taking on more debt over the years, as indicated by the increasing trend in total liabilities.
8. The fluctuations in shareholders' equity suggest varying profitability or capital injections into the company.
9. The company seems to have a stable cash position, with fluctuations in cash and cash equivalents over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020 and its lowest in 2022.
5. Financing activities show significant variations, especially in terms of common stock repurchase and long-term debt issuance.
6. Investing activities also vary, with notable amounts spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial activities show a mix of stability and fluctuations, indicating a dynamic financial strategy.
MACD of ATRC
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
